Fortress Biotech, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Expenses (Tables)

Accounts Payable and Accrued Expenses (Tables)

9 Months Ended

Sep. 30, 2023

Accounts Payable and Accrued Expenses

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following:


		September 30,				December 31,
($ in thousands)		2023			2022

Accounts payable		$	44,731		$	57,244
Accrued expenses:
Professional fees			2,295			1,693
Salaries, bonus and related benefits			8,585			9,772
Research and development			7,446			7,390
Research and development - license maintenance fees			4,456			632
Research and development - milestones			—			4,600
Accrued royalties payable			1,794			2,627
Accrued coupon and rebates			6,099			7,604
Return reserve			4,523			3,689
Accrued interest			16			342
Other			1,461			1,853
Total accounts payable and accrued expenses		$	81,406		$	97,446